# Amelanotic Melanoma of the Sinonasal Region: Diagnostic Challenges

**Authors:** Irianiwati Widodo, Sagung Rai Indrasari, Tri Budiarti, Naomi Yoshuantari, Ery Kus Dwianingsih

PMC · DOI: 10.30699/ijp.2025.2052388.3414 · Iranian Journal of Pathology · 2025-08-15

## TL;DR

This paper discusses a rare case of amelanotic melanoma in the nasal area, emphasizing the difficulty in diagnosis and the importance of immunohistochemistry.

## Contribution

The paper presents a unique case of amelanotic melanoma and highlights the critical role of immunohistochemical markers in diagnosis.

## Key findings

- Amelanotic melanoma lacks pigmentation, making it hard to diagnose clinically.
- Immunohistochemistry with S100, HMB45, and Melan-A confirmed the diagnosis in this case.
- Differential diagnoses like lymphoma and squamous cell carcinoma were ruled out using IHC.

## Abstract

Sinonasal melanoma is an aggressive malignancy with a poor prognosis, largely due to its propensity for local invasion and early metastasis. Diagnosis is often difficult, particularly in the absence of melanin pigmentation. Histopathological and immunohistochemical (IHC) evaluation is essential for confirmation. This report describes a diagnostically challenging case of amelanotic melanoma of the sinonasal region.

A 56-year-old woman presented with a 5-month history of epistaxis, facial pain, and visual impairment of the left eye. Clinical examination revealed a mass in the left nasal cavity, initially diagnosed as sinonasal carcinoma. Histopathology suggested a differential diagnosis of non-Hodgkin lymphoma (NHL) and poorly differentiated squamous cell carcinoma (SCC). Imaging demonstrated a sinonasal tumor involving the left extraconal orbital wall and paranasal sinuses. A biopsy initially raised suspicion for NHL; however, IHC staining was negative for CD45, CD20, and CD3. Similarly, negative P40 and cytokeratin excluded SCC. Strong immunoreactivity for S100, HMB45, and Melan-A established the diagnosis of amelanotic melanoma.

Amelanotic melanoma of the sinonasal tract poses a significant diagnostic challenge due to nonspecific clinical features and lack of pigmentation. This case highlights the indispensable role of IHC in achieving a definitive diagnosis.

## Linked entities

- **Proteins:** S100A1 (S100 calcium binding protein A1), PMEL (premelanosome protein), PTPRC (protein tyrosine phosphatase receptor type C), MS4A1 (membrane spanning 4-domains A1), cd.3 (Cd.3 conserved hypothetical protein), IL9 (interleukin 9), krt12.4.S (Keratin 12, gene 4 S homeolog)
- **Diseases:** melanoma (MONDO:0005105), non-Hodgkin lymphoma (MONDO:0018908), squamous cell carcinoma (MONDO:0005096)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, MLANA (melan-A) [NCBI Gene 2315] {aka MART-1, MART1}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}
- **Diseases:** metastasis (MESH:D009362), Amelanotic Melanoma (MESH:D018328), epistaxis (MESH:D004844), NHL (MESH:D008228), malignancy (MESH:D009369), pigmentation (MESH:D010859), Sinonasal melanoma (MESH:D008545), sinonasal carcinoma (MESH:C537344), SCC (MESH:D002294), facial pain (MESH:D005157), visual impairment (MESH:D014786)
- **Chemicals:** melanin (MESH:D008543)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12520598/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12520598/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12520598/full.md

---
Source: https://tomesphere.com/paper/PMC12520598